Equities

Medpace Holdings Inc

Medpace Holdings Inc

Actions
  • Price (EUR)329.20
  • Today's Change3.60 / 1.11%
  • Shares traded45.00
  • 1 Year change+38.61%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments24528461
Total Receivables, Net298253186
Total Inventory------
Prepaid expenses505243
Other current assets, total------
Total current assets594334691
Property, plant & equipment, net265249223
Goodwill, net662662662
Intangibles, net363841
Long term investments------
Note receivable - long term------
Other long term assets252117
Total assets1,6571,3521,660
LIABILITIES
Accounts payable323326
Accrued expenses315229176
Notes payable/short-term debt0500
Current portion long-term debt/capital leases------
Other current liabilities, total578491356
Total current liabilities925803557
Total long term debt000
Total debt0500
Deferred income tax2.401.071.08
Minority interest------
Other liabilities, total170162149
Total liabilities1,098966707
SHAREHOLDERS EQUITY
Common stock0.310.310.36
Additional paid-in capital803771728
Retained earnings (accumulated deficit)(222)(360)235
Treasury stock - common(12)(12)(5.43)
Unrealized gain (loss)------
Other equity, total(10)(12)(4.85)
Total equity559386953
Total liabilities & shareholders' equity1,6571,3521,660
Total common shares outstanding313136
Treasury shares - common primary issue0.070.070.18
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.